Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Tilray Inc buy Maxfloh

Start price
€39.08
13.07.19 / 50%
Target price
€108.24
27.01.20
Performance (%)
-55.22%
End price
€17.50
27.01.20
Summary
This prediction ended on 27.01.20 with a price of €17.50. Massive losses of -55.22% were the result for the BUY prediction by Maxfloh. Maxfloh has 50% into this prediction

Tilray, Inc. is a Canadian-based pharmaceutical and cannabis company that is listed on the NASDAQ exchange under the ticker symbol TLRY. The company specializes in the research, cultivation, production, and distribution of medical cannabis products worldwide. Founded in 2013, Tilray has become one of the largest cannabis companies in the world with operations in North America, Europe, and Australia. The company's main areas of focus are medical research and development, consumer brands, as well as global distribution partnerships. As a publicly traded company, Tilray's stock price is subject to market fluctuations and investor sentiment towards the cannabis industry.

Performance without dividends (%)
Name 1w 1m 1y 3y
Tilray Inc -14.105% -14.105% -78.620% -
iShares Core DAX® 2.149% 5.415% 21.385% 22.595%
iShares Nasdaq 100 0.838% 1.926% 44.386% 55.330%
iShares Nikkei 225® 1.143% 2.887% 27.641% 9.481%
iShares S&P 500 1.265% 3.698% 33.327% 49.646%

Comments by Maxfloh for this prediction

In the thread Tilray Inc diskutieren
Prediction Buy
Perf. (%) -55.22%
Target price 108.240
Change
Ends at 27.01.20

Maxfloh stimmt der Buy-Einschätzung von melinda zu

Maxfloh stimmt am 13.07.2019 der Buy-Einschätzung von melinda mit dem Kursziel 93$ zu.
Überschrift: SecteurProduits pharmaceutiques

Prediction Buy
Perf. (%) -55.22%
Target price 108.240
Change
Ends at 27.01.20

Buy beendet